Related Experiment Videos
Primer: an evidence-based approach to prognostic markers.
Douglas G Altman1, Richard D Riley
1Cancer Research UK Medical Statistics Group, Centre for Statistics in Medicine, Wolfson College, Oxford, UK. doug.altman@cancer.org.uk
Nature Clinical Practice. Oncology
|November 3, 2005
Summary
Prognostic marker studies are crucial for patient risk assessment and treatment decisions. Improving their quality requires evidence-based approaches and pooled analyses for reliable clinical insights.
Area of Science:
- Medical research methodology
- Clinical epidemiology
- Biostatistics
Background:
- Prognostic markers aid in identifying patient risk, guiding treatment choices, and informing patient counseling.
- Despite their widespread use, prognostic studies are often neglected in medical research quality improvement efforts.
- Published prognostic studies frequently lack rigorous methodology and clear reporting standards.
Purpose of the Study:
- To highlight common problems in published prognostic studies.
- To propose improvements for enhancing the quality and reliability of prognostic research.
- To advocate for an evidence-based approach to prognostic marker evaluation.
Main Methods:
- Discussion of common deficiencies in prognostic study designs and reporting.
- Emphasis on the need for systematic reviews and meta-analyses of high-quality studies.
- Recommendation for prospectively planned pooled analyses and individual patient data sharing.
Main Results:
- Published prognostic studies often fail to meet quality standards, hindering clinical application.
- Existing systematic reviews and meta-analyses frequently reveal a lack of high-quality evidence.
- A clear understanding of marker benefit typically emerges only from aggregated data across multiple studies.
Conclusions:
- An evidence-based approach is essential for evaluating prognostic markers, moving beyond single-study limitations.
- Improving the quality of prognostic research requires standardized reporting and robust methodologies.
- Pooled analyses of high-quality prospective studies are vital for generating reliable clinical evidence.